Lucia Bianchi

1.9k total citations
24 papers, 971 citations indexed

About

Lucia Bianchi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Lucia Bianchi has authored 24 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Lucia Bianchi's work include Multiple Sclerosis Research Studies (8 papers), Acute Myeloid Leukemia Research (4 papers) and Polyomavirus and related diseases (4 papers). Lucia Bianchi is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Acute Myeloid Leukemia Research (4 papers) and Polyomavirus and related diseases (4 papers). Lucia Bianchi collaborates with scholars based in Italy, United Kingdom and United States. Lucia Bianchi's co-authors include Alessandro M. Vannucchi, Anna Ritá Migliaccio, Giovanni Migliaccio, R Lorenzini, Rosa Alba Rana, Francesco Paoletti, Cristina Cellai, Massimo Sanchez, Lucia Centurione and Stuart H. Orkin and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Nature Cell Biology.

In The Last Decade

Lucia Bianchi

24 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucia Bianchi Italy 13 487 366 363 158 157 24 971
Christine Tran Quang France 12 620 1.3× 403 1.1× 269 0.7× 289 1.8× 507 3.2× 21 1.3k
Idoya Lahortiga Spain 20 672 1.4× 595 1.6× 260 0.7× 207 1.3× 226 1.4× 40 1.3k
Jennifer Adelsperger United States 5 417 0.9× 444 1.2× 155 0.4× 222 1.4× 101 0.6× 6 793
Ulrike Huffstadt Germany 5 361 0.7× 169 0.5× 217 0.6× 218 1.4× 391 2.5× 7 850
Mario Notari Italy 9 711 1.5× 363 1.0× 233 0.6× 60 0.4× 159 1.0× 11 1.0k
Elisa Bianchi Italy 17 465 1.0× 372 1.0× 349 1.0× 91 0.6× 70 0.4× 35 900
Claudiu Cotta United States 16 294 0.6× 182 0.5× 123 0.3× 126 0.8× 133 0.8× 50 638
Abdullah Mahmood Ali United States 20 1.5k 3.0× 319 0.9× 147 0.4× 116 0.7× 244 1.6× 60 2.0k
François Morlé France 18 631 1.3× 349 1.0× 314 0.9× 101 0.6× 48 0.3× 49 1.1k
Siamak Jabbarzadeh‐Tabrizi Japan 10 314 0.6× 247 0.7× 99 0.3× 252 1.6× 172 1.1× 13 652

Countries citing papers authored by Lucia Bianchi

Since Specialization
Citations

This map shows the geographic impact of Lucia Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Bianchi more than expected).

Fields of papers citing papers by Lucia Bianchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Bianchi. The network helps show where Lucia Bianchi may publish in the future.

Co-authorship network of co-authors of Lucia Bianchi

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Bianchi. A scholar is included among the top collaborators of Lucia Bianchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Bianchi. Lucia Bianchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ammoscato, Francesca, Jonathan P. Bestwick, Michael Andrews, et al.. (2024). Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells. Clinical Immunology. 269. 110380–110380. 4 indexed citations
2.
Dobson, Ruth, David W. Holden, Nicola Vickaryous, et al.. (2023). A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis. Multiple Sclerosis Journal. 30(1). 63–70. 1 indexed citations
3.
MacDougall, Amy, Ashok Adams, Lucia Bianchi, et al.. (2023). Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 16. 4223481715–4223481715. 5 indexed citations
4.
Adams, Ashok, Jonathan P. Bestwick, David W. Holden, et al.. (2022). The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis. European Journal of Neurology. 29(9). 2754–2760. 5 indexed citations
5.
Smets, Ide, David W. Holden, Lucia Bianchi, et al.. (2021). Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Multiple Sclerosis and Related Disorders. 57. 103409–103409. 3 indexed citations
6.
Reyes, Saúl, Ide Smets, David W. Holden, et al.. (2020). CSF neurofilament light chain testing as an aid to determine treatment strategies in MS. Neurology Neuroimmunology & Neuroinflammation. 7(6). 15 indexed citations
7.
Anderson, Valerie, Sam Loveless, Lucia Bianchi, et al.. (2020). Serum neurofilament-light concentration and real-world outcome in MS. Journal of the Neurological Sciences. 417. 117079–117079. 15 indexed citations
8.
Gold, Julian, Mónica Marta, Ute‐Christiane Meier, et al.. (2018). A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple Sclerosis and Related Disorders. 24. 123–128. 26 indexed citations
9.
Mannurita, Sara Ciullini, Marina Vignoli, Lucia Bianchi, et al.. (2013). CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort. European Journal of Human Genetics. 22(2). 197–201. 28 indexed citations
10.
Savasta, Salvatore, et al.. (2010). Ehlers–Danlos syndrome and neurological features: a review. Child s Nervous System. 27(3). 365–371. 23 indexed citations
11.
Campaner, Stefano, Mirko Doni, Per Hydbring, et al.. (2009). Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nature Cell Biology. 12(1). 54–59. 207 indexed citations
12.
Barberio, Claudia, Lucia Bianchi, Tiziana Lodi, et al.. (2007). Induction and characterization of morphologic mutants in a natural Saccharomyces cerevisiae strain. Canadian Journal of Microbiology. 53(2). 223–230. 2 indexed citations
13.
Gambineri, Eleonora, et al.. (2006). F.92. Turner'S Syndrome and Autoimmunity: Role of FOXP3 and Regulatory T-Cells. Clinical Immunology. 119. S83–S83. 1 indexed citations
14.
Vannucchi, Alessandro M., Alessandro Pancrazzi, Paola Guglielmelli, et al.. (2005). Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic Myelofibrosis. American Journal Of Pathology. 167(3). 849–858. 58 indexed citations
15.
Vannucchi, Alessandro M., Lucia Bianchi, Francesco Paoletti, et al.. (2005). A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis. Blood. 105(9). 3493–3501. 87 indexed citations
16.
Vannucchi, Alessandro M., Lucia Bianchi, Francesco Paoletti, et al.. (2004). Impaired GATA-1 expression and myelofibrosis in an animal model. Pathologie Biologie. 52(5). 275–279. 7 indexed citations
17.
Cellai, Cristina, et al.. (2002). Specific PAF antagonist WEB‐2086 induces terminal differentiation of murine and human leukemia cells. The FASEB Journal. 16(7). 733–735. 19 indexed citations
18.
Vannucchi, Alessandro M., Lucia Bianchi, Cristina Cellai, et al.. (2002). Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice). Blood. 100(4). 1123–1132. 174 indexed citations
19.
Chetoni, Patrizia, Lucia Bianchi, B. Giannaccini, et al.. (1996). Ocular Mini-Tablets for Controlled Release of Timolol: Evaluation in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 12(3). 245–252. 11 indexed citations
20.
Monti, Daniela, et al.. (1996). [Preparation and "in vitro" and "in vivo" evaluation of a transdermal formulation containing methimazole].. PubMed. 135(2). 139–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Tran Quang Breakdown of academic impact, for papers by Idoya Lahortiga Breakdown of academic impact, for papers by Jennifer Adelsperger Breakdown of academic impact, for papers by Ulrike Huffstadt Breakdown of academic impact, for papers by Mario Notari Breakdown of academic impact, for papers by Elisa Bianchi Breakdown of academic impact, for papers by Claudiu Cotta Breakdown of academic impact, for papers by Abdullah Mahmood Ali Breakdown of academic impact, for papers by François Morlé Breakdown of academic impact, for papers by Siamak Jabbarzadeh‐Tabrizi
Rankless by CCL
2026